Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials

By afschroeder • September 9, 2026

Hageen AW, Gadelmawla AF, Saleh AO, Bahnasy S, Eladawi S, Abdelaziz M, Iyad K, Kandil AH, Zinhom K, Mohamed MR, Abdulhay H, Turkman M, Abdelazeem B, Fonarow GC. Efficacy and Safety of Tirzepatide Versus Dulaglutide in Type 2 Diabetes With or Without Established Atherosclerotic Cardiovascular Disease: A Network Meta-Analysis of Randomized Clinical Trials. Endocrinol Diabetes Metab. 2026 Sep;9(5):e70313. doi: 10.1002/edm2.70313. PMID: 42706739; PMCID: PMC13550879.

Tags: Cardiology/Epi, cardiometabolic outcomes, dulaglutide, Publications, RCTs, tirzepatide, Type 2 diabetes mellitus

Association of RSV Vaccination With Clinical Outcomes in Older Adults With Heart Failure: A Propensity-Matched Analysis

Khan A, Shabbir MR, Nasrallah J, Imtiaz M, Thyagaturu H, Fudim M, Mentz RJ, Fonarow GC. Association of RSV Vaccination With Clinical Outcomes in Older[...]

Trends in Guideline Directed Medical Therapy Use in Heart Failure With a Mildly Reduced Ejection Fraction

Girard AA, Martinez OC, Ikeaba U, Jawad MA, Ikemura N, Chiswell K, Greene SJ, Fonarow GC, Chan PS, Sauer AJ, Spertus JA. Trends in Guideline[...]

Coronary Artery Calcium in ACC/AHA Prevention Guidelines: Evolution From 2007 to 2026

Irannejad K, Mora R, Krishnan S, Lakshmanan S, Roy S, Budoff MJ. Coronary Artery Calcium in ACC/AHA Prevention Guidelines: Evolution From 2007 to 2026. JACC[...]